May 10 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES NEW $300 MILLION SHARE REPURCHASE AUTHORIZATION AND QUARTERLY DIVIDEND.BRUKER CORP - APPROVED $300 MILLION SHARE REPURCHASE OVER A TWO-YEAR PERIOD COMMENCING MAY 14, 2019.BRUKER CORP - INTENDS TO FUND REPURCHASES FROM CASH ON HAND, AVAILABLE BORROWINGS UNDER ITS EXISTING CREDIT FACILITY.
Full Article
May 2 (Reuters) - Bruker Corp ::BRUKER REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $0.28.Q1 GAAP EARNINGS PER SHARE $0.20.Q1 REVENUE $461.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $450.1 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.24 -- REFINITIV IBES DATA.RAISING FULL YEAR GUIDANCE FOR REVENUE GROWTH AND EARNINGS.SEES FY ORGANIC REVENUE GROWTH OF 4.5% TO 5.5%;.SEES FY CONSTANT CURRENCY REVENUE GROWTH OF 9.5% TO 10.5%;.SEES FY NON-GAAP OPERATING MARGIN EXPANSION OF 90 BPS TO 120 BPS.SEES FY NON-GAAP EPS OF $1.57 TO $1.61.FY2019 EARNINGS PER SHARE VIEW $1.57, REVENUE VIEW $2.02 BILLION -- REFINITIV IBES DATA.
Full Article
June 4 (Reuters) - Bruker Corp ::BRUKER ACQUIRES SIERRA SENSORS TO EXPAND REAL-TIME, LABEL-FREE DETECTION PORTFOLIO FOR PHARMA AND BIOPHARMA DRUG DISCOVERY.BRUKER CORP - FINANCIAL DETAILS WERE NOT DISCLOSED.
Full Article
March 14 (Reuters) - Bruker Corp ::BRUKER APPOINTS GERALD HERMAN AS INTERIM CHIEF FINANCIAL OFFICER.BRUKER - APPOINTED GERALD HERMAN TO SERVE AS CO'S INTERIM CFO EFFECTIVE AS OF MARCH 17.
Full Article
March 2 (Reuters) - Bruker Corp ::BRUKER CORP FILES FOR NON-TIMELY 10-K - SEC FILING.BRUKER CORP SAYS CO IS IN PROCESS OF ANALYZING TIMING OF CERTAIN SALES TRANSACTIONS WITHIN DIVISION IN 2014, 2015 AND 2016.BRUKER CORP SAYS DOES NOT EXPECT COMPLETION OF REVIEW OF INFORMATION TO RESULT IN MATERIAL CHANGE TO CO’S PREVIOUSLY ANNOUNCED FISCAL 2017 RESULTS.BRUKER CORP SAYS EXPECTS TO FILE FORM 10-K NO LATER THAN FIFTEENTH CALENDAR DAY FOLLOWING THE PRESCRIBED DUE DATE.
Full Article
Feb 22 (Reuters) - Bruker Corp ::BRUKER ACQUIRES HIGH-SPEED QCL INFRARED MICROSCOPY COMPANY IRM2.BRUKER CORP - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED..BRUKER CORP - FINANCIAL DETAILS OF TRANSACTION WERE NOT DISCLOSED..
Full Article
Feb 21 (Reuters) - Bruker Corp ::BRUKER ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND APPOINTMENT OF PRINCIPAL ACCOUNTING OFFICER.BRUKER CORP - ANTHONY MATTACCHIONE, CHIEF FINANCIAL OFFICER, HAS SUBMITTED HIS RESIGNATION, EFFECTIVE AS OF MARCH 16, 2018.BRUKER CORP - FINANCIAL GUIDANCE FOR 2018 REMAINS UNCHANGED.
Full Article
Feb 8 (Reuters) - Bruker Corp ::BRUKER REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.51.Q4 REVENUE ROSE 12.8 PERCENT TO $530.5 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.34 TO $1.38.Q4 GAAP LOSS PER SHARE $0.02.SEES FY 2018 REVENUE UP ABOUT 7 PERCENT.DUE TO EFFECTS OF U.S. TAX REFORM RECORDED A CHARGE OF $68.9 MILLION IN QUARTER.
Full Article
Nov 2 (Reuters) - Bruker Corp :Bruker reports third quarter 2017 financial results.Sees FY 2017 non-GAAP earnings per share $1.17 to $1.20.Q3 non-GAAP earnings per share $0.29.Q3 GAAP earnings per share $0.23.Q3 revenue $435.6 million versus I/B/E/S view $414.6 million.Sees FY 2017 revenue up 8 to 8.5 percent.Q3 earnings per share view $0.26 -- Thomson Reuters I/B/E/S.Bruker Corp - for FY 2017, company now expects revenue growth of 8% to 8.5%.Bruker Corp - sees FY 2017 non-GAAP EPS of $1.17 to $1.20.
Full Article
Sept 26 (Reuters) - Bruker Corp :Bruker announces acquisition of Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper® microbial identification platform.Bruker announces acquisition of Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper® microbial identification platform.Bruker Corp - financial details were not disclosed..
Full Article
Earnings vs. 
Estimates